These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33932512)

  • 1. Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis.
    Wei J; Ma L; Liu W; Wang Y; Shen C; Zhao X; Zhao C
    J Ethnopharmacol; 2021 Aug; 276():114174. PubMed ID: 33932512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the mechanism of quercetin in Sini Decoction Plus Ginseng Soup to inhibit liver cancer and HBV virus replication through CDK1.
    Hao L; Li S; Chen G; Nie A; Zeng L; Xiao Z; Hu X
    Chem Biol Drug Des; 2024 Jun; 103(6):e14567. PubMed ID: 38858165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing
    Li M; Shang H; Wang T; Yang SQ; Li L
    World J Gastroenterol; 2021 Mar; 27(10):939-958. PubMed ID: 33776365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma.
    Li X; Zhou M; Chen W; Sun J; Zhao Y; Wang G; Wang B; Pan Y; Zhang J; Xu J
    BMC Complement Med Ther; 2024 May; 24(1):208. PubMed ID: 38816744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.
    Wang LL; Liao C; Li XQ; Dai R; Ren QW; Shi HL; Wang XP; Feng XS; Chao X
    Med Sci Monit; 2021 Jan; 27():e927624. PubMed ID: 33436534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals Potential Mechanisms of Shelian Capsule against Hepatocellular Carcinoma.
    Zhou X; Tan F; Zhang S; Wang A; Zhang T
    Curr Pharm Des; 2024; 30(5):377-405. PubMed ID: 38310567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics.
    Wan Y; Jiang H; Liu Z; Bai C; Lian Y; Zhang C; Zhang Q; Huang J
    Curr Pharm Des; 2024; 30(24):1894-1911. PubMed ID: 38747231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis.
    Duan ZW; Liu Y; Zhang PP; Hu JY; Mo ZX; Liu WQ; Ma X; Zhou XH; Wang XH; Hu XH; Wei SL
    J Ethnopharmacol; 2024 Sep; 331():118293. PubMed ID: 38705430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of
    Liang Y; Xie Y; Liu X; Yu L; Yan H; Shang Z; Wu Y; Cai X; Shi W; Du J; Yang Z
    Drug Des Devel Ther; 2024; 18():2169-2187. PubMed ID: 38882048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
    Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
    J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
    Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β,β-Dimethylacrylalkannin, a key component of Zicao, induces cell cycle arrest and necrosis in hepatocellular carcinoma cells.
    Shen LS; Chen JW; Gong RH; Lin Z; Lin YS; Qiao XF; Hu QM; Yang Y; Chen S; Chen GQ
    Phytomedicine; 2024 Nov; 134():155959. PubMed ID: 39178682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.
    Zhou R; Wu K; Su M; Li R
    Environ Toxicol Pharmacol; 2019 Aug; 70():103200. PubMed ID: 31158732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the anti-hepatocellular carcinoma effects of Xianglian Pill: Integrating network pharmacology and RNA sequencing via in silico and in vitro studies.
    Huang J; Shi R; Chen F; Tan HY; Zheng J; Wang N; Li R; Wang Y; Yang T; Feng Y; Zhong Z
    Phytomedicine; 2024 Oct; 133():155905. PubMed ID: 39128301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of Codonopsis pilosula in inhibiting hepatocellular carcinoma growth and metastasis.
    Li N; Yang C; Xia J; Wang W; Xiong W
    Phytomedicine; 2024 Jun; 128():155338. PubMed ID: 38520835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Network Pharmacology with in vitro Experiments to Validate the Efficacy of Celastrol Against Hepatocellular Carcinoma Through Ferroptosis.
    Cai B; Qi M; Zhang X; Zhang D
    Drug Des Devel Ther; 2024; 18():3121-3141. PubMed ID: 39071814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC).
    Shen HY; Li XQ; Fan WQ; Wang YW; Huang F; Wu JQ; Zhang W; Feng XS; Chao X
    Eur J Pharmacol; 2021 Oct; 909():174405. PubMed ID: 34384755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
    Li L; Huang K; Zhao H; Chen B; Ye Q; Yue J
    Cell Cycle; 2020 May; 19(10):1236-1252. PubMed ID: 32275843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of emodin in treating hepatitis B virus-associated hepatocellular carcinoma: network pharmacology and cell experiments.
    Wang Y; Li S; Ren T; Zhang Y; Li B; Geng X
    Front Cell Infect Microbiol; 2024; 14():1458913. PubMed ID: 39346898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.